论文部分内容阅读
目的:探讨α1受体阻滞剂在双J管综合征防治中的临床意义。方法:回顾性分析2009年2月～2012年1月对肾盂和(或)肾实质切开取石术、开放或腹腔镜下输尿管切开取石术、经皮肾镜取石碎石术共计146例留置双J管的患者临床资料:患者术后拔除尿管、术野引流管或(和)肾造瘘管后分两组,A组68例,服用α1受体阻滞剂20天;B组78例,未服用α1受体阻滞剂,并对两组患者血尿、肋腹区疼痛、尿频/尿急的发生率和持续时间进行统计学分析。结果:A组患者血尿、肋腹区疼痛、尿频/尿急的发生率较低,持续时间较短,与B组的对照P值分别是0.0249、0.0051、0.0005,两组差异有统计学意义。结论:服用α1受体阻滞剂有利于防治双J管综合征的发生。
Objective: To investigate the clinical significance of α1-blocker in the prevention and treatment of double-J tube syndrome. Methods: A retrospective analysis of the pelvis and / or renal parenchyma between January 2009 and January 2012 was performed. Open or laparoscopic ureterolithotomy and percutaneous nephrolithotomy were performed in 146 cases The clinical data of patients with double-J tube: The patients were divided into two groups after operation: the catheter was removed, the drainage tube of the surgical field or (and) the renal fistula was divided into two groups, 68 cases in group A and α1 receptor antagonist for 20 days; 78 cases in group B , Did not take α1 blockers, and the two groups of patients with hematuria, rib belly pain, frequent urination / urgency and duration of the incidence of statistical analysis. Results: The hematuria, abdominal pain and frequent urination / urgency were lower in group A than those in group B, and the values of control P in group A were 0.0249,0.0051 and 0.0005, respectively. The differences between the two groups were statistically significant. Conclusion: taking α1 receptor blockers is conducive to the prevention and treatment of double J tube syndrome.